<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Reward Valuation | Neuro Adx Lab</title><link>https://www.neuro-adx-lab.com/tags/reward-valuation/</link><atom:link href="https://www.neuro-adx-lab.com/tags/reward-valuation/index.xml" rel="self" type="application/rss+xml"/><description>Reward Valuation</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Wed, 22 Apr 2026 00:00:00 +0000</lastBuildDate><image><url>https://www.neuro-adx-lab.com/media/logo_hu_9de78bf642a435bd.png</url><title>Reward Valuation</title><link>https://www.neuro-adx-lab.com/tags/reward-valuation/</link></image><item><title>Developing and Validating a Scale to Assess Differential Valuation of Substance-Related Rewards Versus Natural and Other Non-Drug Rewards in Addiction</title><link>https://www.neuro-adx-lab.com/projects/reward-scale/</link><pubDate>Wed, 22 Apr 2026 00:00:00 +0000</pubDate><guid>https://www.neuro-adx-lab.com/projects/reward-scale/</guid><description>&lt;div style="text-align:center; margin-bottom:2rem;"&gt;
&lt;img src="reward-scale-full.png" alt="Developing and Validating a Scale to Assess Differential Valuation of Substance-Related Rewards" style="width:100%; max-width:1200px;" /&gt;
&lt;/div&gt;
&lt;h2 id="project-overview"&gt;Project Overview&lt;/h2&gt;
&lt;p style="text-align:justify;"&gt;Several influential models and theories of substance use and addiction propose that individuals with substance use disorders show an increased motivational valuation of drug-related rewards, at the expense of natural rewards and other rewarding activities. This project builds on these theoretical frameworks by integrating qualitative methods, quantitative psychometric approaches, expert consensus procedures, and recent advances in artificial intelligence (AI) and large language models to develop and validate a new psychological assessment scale. This scale will be designed to measure the differential valuation of substance-related rewards versus natural rewards and other non-drug rewarding activities. By doing so, the project aims to provide a theoretically grounded, clinically relevant, and psychometrically robust instrument for assessing reward-processing dysregulation in addiction.&lt;/p&gt;
&lt;h2 id="background"&gt;Background&lt;/h2&gt;
&lt;p style="text-align:justify;"&gt;The chronic use of alcohol and other drugs leads to changes in motivational and reward-processing systems, whereby substance-related rewards and cues acquire excessive motivational value while natural rewards and other meaningful non-drug activities are devalued. This motivational imbalance is central to several influential models of addiction and is thought to contribute to craving, compulsive substance use, reduced engagement with alternative sources of reinforcement, and promote relapse risk. Despite its theoretical and clinical importance, there is currently a lack of psychometrically validated self-report instruments specifically designed to assess the differential valuation of substance-related rewards relative to natural rewards and other rewarding activities. This project addresses this gap by developing and validating a new theoretically grounded scale that captures this reward-valuation imbalance across different patterns of alcohol and other drug use.&lt;/p&gt;
&lt;h2 id="research-objectives"&gt;Research Objectives&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Identify psychologically and clinically relevant content domains related to reward valuation in substance use&lt;/li&gt;
&lt;li&gt;Generate and refine candidate items using qualitative data, expert input, and AI-assisted psychometric methods&lt;/li&gt;
&lt;li&gt;Evaluate the content validity, clarity, relevance, and theoretical adequacy of the items&lt;/li&gt;
&lt;li&gt;Test the factor structure, reliability, and validity of the final scale&lt;/li&gt;
&lt;li&gt;Examine whether the scale can distinguish between individuals with different levels of substance use involvement and addiction-related risk&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id="methodology"&gt;Methodology&lt;/h2&gt;
&lt;p style="text-align:justify;"&gt;The study adopts a multi-method design that integrates qualitative, computational, expert-based, and quantitative procedures:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Semi-structured interviews will be conducted with individuals with different histories and patterns of alcohol and other drug use&lt;/li&gt;
&lt;li&gt;Qualitative data will be analyzed using both traditional content-analytic procedures and AI-assisted approaches based on large language models&lt;/li&gt;
&lt;li&gt;AI-assisted psychometric development procedures, including AI-GENIE — Automatic Item Generation and Validation with Network-Integrated Evaluation — to support the generation, refinement, and preliminary evaluation of candidate items&lt;/li&gt;
&lt;li&gt;Delphi methodology will be used to obtain structured feedback from experts in addiction, clinical psychology, psychometrics, and reward processing&lt;/li&gt;
&lt;li&gt;Quantitative validation studies will be conducted to assess the psychometric properties of the scale (i.e., dimensional structure, internal consistency, test-retest reliability, convergent and discriminant validity, criterion validity, and ability to differentiate between groups with distinct patterns of substance use)&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id="significance"&gt;Significance&lt;/h2&gt;
&lt;p style="text-align:justify;"&gt;This project aims to make a significant contribution to the addiction literature by developing and validating a theoretically informed, clinically useful, and psychometrically robust self-report instrument for assessing reward-processing dysregulation in substance use. The resulting scale is expected to provide a rapid, reliable, low-cost, and scalable method for assessing the extent to which substance-related rewards are overvalued relative to natural rewards and other rewarding activities. This is clinically important because such motivational imbalance is thought to play a central role in the development, maintenance, and relapse of substance use disorders.&lt;/p&gt;</description></item></channel></rss>